Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Breast Cancer Brain Metastases”

248 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 248 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT02650401
What this trial is testing

Study Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment Options

Who this might be right for
Solid TumorsCNS Tumors
Hoffmann-La Roche 69
Not applicableStudy completedNCT02898727
What this trial is testing

Local Therapy for the Treatment of Brain Metastases From HER2 Positive Breast Cancer

Who this might be right for
Breast Neoplasms
Trans Tasman Radiation Oncology Group 25
Testing effectiveness (Phase 2)UnknownNCT05018702
What this trial is testing

ARX788 in HER2-positive Breast Cancer Patients With Brain Metastases

Who this might be right for
HER2-positive, Metastatic Breast Cancer
Fudan University 32
Early research (Phase 1)Ended earlyNCT02598427
What this trial is testing

Intrathecal Pertuzumab and Trastuzumab in Patients With New Untreated Asymptomatic or Low Symptomatic Brain Metastasis in HER2 Positive Breast Cancer

Who this might be right for
HER2 Positive Untreated Metastatic Breast CancerAsymptomatic or Low Symptomatic Brain Metastasis in Breast Cancer
Kimberly Blackwell 1
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07150208
What this trial is testing

T-DXd With or Without Bevacizumab for HER2-low Breast Cancer With Brain Metastasis

Who this might be right for
Breast Cancer With Brain MetastasisHER2-low Expressing Breast Cancer
Fudan University 140
Not applicableUnknownNCT03896958
What this trial is testing

The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)

Who this might be right for
Cancer, All TypesCancer of LiverCancer of Stomach+42 more
SpeciCare 1,000
Testing effectiveness (Phase 2)Looking for participantsNCT05386108
What this trial is testing

Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer

Who this might be right for
Breast NeoplasmsBrain NeoplasmsNeoplasms by Site+5 more
Stemline Therapeutics, Inc. 73
Testing effectiveness (Phase 2)Study completedNCT02312622
What this trial is testing

Phase 2 Etirinotecan Pegol in Refractory Brain Metastases & Advanced Lung Cancer / Metastatic Breast Cancer

Who this might be right for
Stage IV Non-small Cell Lung Cancer (NSCLC)Recurrent Non-small Cell Lung Cancer (NSCLC)Extensive-stage Small Cell Lung Cancer (SCLC)+3 more
Joel Neal 27
Not applicableLooking for participantsNCT06330870
What this trial is testing

Brain Metastasis Development Mechanism in BCBM Patients

Who this might be right for
Breast CancerBrain Metastasis
Samsung Medical Center 30
Large-scale testing (Phase 3)UnknownNCT01782274
What this trial is testing

Proteome-based Immunotherapy of Brain Metastases From Breast Cancer

Who this might be right for
Neoplasm Metastasis
NeuroVita Clinic 60
Not applicableUnknownNCT03617341
What this trial is testing

Brain Monitoring for High Risk of Brain Metastases in Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer With HER2 PositiveTriple Negative Breast Cancer
Yonsei University 200
Early research (Phase 1)Study completedNCT02223052
What this trial is testing

Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies

Who this might be right for
Hematological NeoplasmsNon-Hodgkin's LymphomaHodgkin's Lymphoma+17 more
Celgene 89
Testing effectiveness (Phase 2)Ended earlyNCT00538343
What this trial is testing

RTA 744 in Breast Cancer Patients With Progression of Previously Irradiated Brain Metastases

Who this might be right for
Brain Metastases
Biogen 14
Very early researchStudy completedNCT04752267
What this trial is testing

18F-FMAU PET/CT and MRI for the Detection of Brain Tumors in Patients With Brain Cancer or Brain Metastases

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Glioma+17 more
University of Southern California 10
Testing effectiveness (Phase 2)Study completedNCT00263588
What this trial is testing

Lapatinib for Brain Metastases In ErbB2-Positive Breast Cancer

Who this might be right for
Neoplasms, Breast
Novartis Pharmaceuticals 242
Not applicableNot Yet RecruitingNCT06015113
What this trial is testing

Efficacy and Safety of Disitamab Vedotin Plus Pyrotinib or Naratinib in HER2-positive Breast Cancer Patients With Brain Metastasis

Who this might be right for
Breast Cancer
Xi'an International Medical Center Hospital 20
Testing effectiveness (Phase 2)WithdrawnNCT03637868
What this trial is testing

Eribulin in Brain Metastases From HER2-negative Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Institut Paoli-Calmettes
Post-approval studies (Phase 4)UnknownNCT04767828
What this trial is testing

A Single Arm Study of Brain Metastasis in Patients With HER2-positive Breast Cancer

Who this might be right for
TTP
Tianjin Medical University Cancer Institute and Hospital 43
Testing effectiveness (Phase 2)Study completedNCT00992602
What this trial is testing

Liposomal Cytarabine and High-Dose Methotrexate in Treating Patients With Central Nervous System Metastases From Breast Cancer

Who this might be right for
Central Nervous System MetastasesLeptomeningeal MetastasesRecurrent Breast Cancer+2 more
University of Washington 3
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06210438
What this trial is testing

SHR-A1921 Combined With Bevacizumab in Triple-negative Breast Cancer With Brain Metastases

Who this might be right for
TNBCBrain Metastasis
Fudan University 24
Load More Results